Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Short Course Oncology Therapy(SCOT). A study of post operative chemotherapy for 12 weeks versus 24 weeks with oxaliplatin/Fluorouracil (5FU) to establish disease free survival outcomes in locally advanced colon cancer

Next Previous
X
Search
Trial Profile

Short Course Oncology Therapy(SCOT). A study of post operative chemotherapy for 12 weeks versus 24 weeks with oxaliplatin/Fluorouracil (5FU) to establish disease free survival outcomes in locally advanced colon cancer

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Fluorouracil
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms SCOT

    • Most Recent Events

    • 08 Jun 2021 Results from 6 randomised trials NCT00749450, NCT00646607, NCT01150045, NCT00958737) in the IDEA database used to compare characteristics, tx adherence, and adverse events presented at the 57th Annual Meeting of the American Society of Clinical Oncology.
    • 13 Jan 2021 Results of the pooled analysis of the high-risk stage II disease individual patient data from the four studies within the IDEA collaboration published in the Journal of Clinical Oncology
    • 14 Dec 2013 Accrual to date is 102% according to United Kingdom Clinical Research Network record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top